AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zambon, S.
Right arrow Articles by Ensinck, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zambon, S.
Right arrow Articles by Ensinck, J. W.
Agricola
Right arrow Articles by Zambon, S.
Right arrow Articles by Ensinck, J. W.

American Journal of Clinical Nutrition, Vol 56, 447-454, Copyright © 1992 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Effect of glyburide and omega 3 fatty acid dietary supplements on glucose and lipid metabolism in patients with non-insulin-dependent diabetes mellitus

S Zambon, KE Friday, MT Childs, WY Fujimoto, EL Bierman and JW Ensinck
Department of Medicine, University of Washington, Seattle.

Using a random crossover design, we examined the effects of glyburide for 4 wk on glucose, insulin, lipid, and lipoprotein metabolism in 10 men with non-insulin-dependent diabetes (NIDDM) receiving dietary fish- oil concentrates containing omega 3 (n-3) fatty acids (8 g/d). Compared with glyburide alone, fasting plasma glucose concentrations increased with fish oil. Although glyburide with fish oil decreased fasting glucose concentrations, they did not return to baseline. Basal insulin concentrations were unaltered by fish oil without or with glyburide; however, postprandial insulin concentrations were decreased by fish oil. Although total cholesterol and triglyceride concentrations were unchanged, very-low-density-lipoprotein cholesterol concentrations decreased and low-density-lipoprotein cholesterol rose and apolipoprotein B concentrations trended higher. Thus, glyburide only partially rectified the impaired fuel homeostasis associated with fish- oil supplements in patients with NIDDM. Therefore, we do not recommend intake of fish oil concentrates containing n-3 fatty acids in patients with NIDDM.


This article has been cited by other articles:


Home page
 HeartHome page
P N Durrington, D Bhatnagar, M I Mackness, J Morgan, K Julier, M A Khan, and M France
An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia
Heart, May 1, 2001; 85(5): 544 - 548.
[Abstract] [Full Text]

Home page
 Am. J. Clin. Nutr.Home page
T. A Mori, D. Q Bao, V. Burke, I. B Puddey, G. F Watts, and L. J Beilin
Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects
Am. J. Clinical Nutrition, November 1, 1999; 70(5): 817 - 825.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
N. J. Stone
Fish Consumption, Fish Oil, Lipids, and Coronary Heart Disease
Circulation, November 1, 1996; 94(9): 2337 - 2340.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by The American Society for Nutrition